MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ahj.2020.01.005

Медицинская библиотека · American heart journal · 2020

Incidence, underlying conditions, and outcomes of patients receiving acute renal replacement therapies in tertiary cardiac intensive care units: An analysis from the Critical Care Cardiology Trials Network Registry.

van Diepen Sean, Tymchak Wayne, Bohula Erin A, Park Jeong-Gun, Daniels Lori B, Phreaner Nicholas, Barnett Christopher F, Kenigsberg Benjamin B, DeFilippis Andrew, Singam Narayana Sarma, Barsness Gregory W, Jentzer Jacob C, Ternus Bradley, Morrow David A, Katz Jason N, Critical Care Cardiology Trials Network Investigators

СтатьяМногоцентровое исследованиеПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

The prevalence of renal disease in cardiac intensive care units (CICUs) is increasing, but little is known about the utilization, concurrent therapies, and outcomes of patients requiring acute renal replacement therapy (RRT) in this specialized environment.

METHODS

In the Critical Care Cardiology Trials Network, 16 centers submitted data on CICU admissions including acute RRT (defined as continuous renal replacement therapy and/or acute intermittent dialysis).

RESULTS

Among 2,985 admissions, 178 (6.0%; interhospital range 1.0%-16.0%) received acute RRT. Patients receiving RRT, versus not, were more commonly admitted for cardiogenic shock (15.7% vs 4.2%, P < .01), cardiac arrest (9.6% vs 3.7%, P < .01), and acute general medical diagnoses (10.7% vs 5.8%, P < .01), whereas acute coronary syndromes (16.9% vs 32.1%, P < .01) were less frequent. Variables independently associated with acute RRT included diabetes, heart failure, liver disease, severe valvular disease, shock, cardiac arrest, hypertension, and younger age. In patients receiving acute RRT, versus not, advanced therapies including mechanical ventilation (55.6% vs 18.0%), vasoactive support (73.0% vs 35.2%), invasive hemodynamic monitoring (59.6% vs 29.2%), and mechanical circulatory support (27.5% vs 8.4%) were more common. Acute RRT was associated with higher in-hospital mortality (42.1% vs 9.3%, adjusted odds ratio 3.74, 95% CI, 2.52-5.53) and longer median length of stay (10.0 vs 5.3 days, P < .01). In conclusion, acute RRT in contemporary CICUs was associated with the provision of other advanced therapies and lower survival.

CONCLUSIONS

These data underscore the risks associated with the provision of renal support in patients with primary cardiovascular problems and the need to develop standardized indications and potential futility measures in this specialized population.

Для цитирования: van Diepen Sean, Tymchak Wayne, Bohula Erin A, Park Jeong-Gun, Daniels Lori B, Phreaner Nicholas, Barnett Christopher F, Kenigsberg Benjamin B, DeFilippis Andrew, Singam Narayana Sarma, Barsness Gregory W, Jentzer Jacob C, Ternus Bradley, Morrow David A, Katz Jason N, Critical Care Cardiology Trials Network Investigators. Incidence, underlying conditions, and outcomes of patients receiving acute renal replacement therapies in tertiary cardiac intensive care units: An analysis from the Critical Care Cardiology Trials Network Registry.. American heart journal. 2020. DOI: 10.1016/j.ahj.2020.01.005.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.